OTCMKTS:RCDTF - Recordati Industria Chimica e Farmaceutica Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $44.00
  • Forecasted Upside: 6.72 %
  • Number of Analysts: 4
  • Breakdown:
  • 1 Sell Ratings
  • 3 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$41.23
+0 (0.00%)

This chart shows the closing price for RCDTF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Recordati Industria Chimica e Farmaceutica Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RCDTF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RCDTF

Analyst Price Target is $44.00
▲ +6.72% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Recordati Industria Chimica e Farmaceutica in the last 3 months. The average price target is $44.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 6.72% upside from the last price of $41.23.

This chart shows the closing price for RCDTF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 4 contributing investment analysts is to hold stock in Recordati Industria Chimica e Farmaceutica.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/12/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
7/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
1/7/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
4/7/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
6/6/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings
7/6/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/28/2022Deutsche Bank AktiengesellschaftLower Price TargetHold ➝ Hold€47.00 ➝ €44.00
11/2/2021BarclaysReiterated RatingEqual Weight
11/1/2021JPMorgan Chase & Co.Reiterated RatingNeutral
9/17/2021BarclaysInitiated CoverageEqual Weight
7/30/2021Oddo BhfDowngradeNeutral ➝ Underperform
6/25/2021JPMorgan Chase & Co.Initiated CoverageNeutral
4/20/2021Deutsche Bank AktiengesellschaftInitiated CoverageHold
10/30/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral
8/4/2020Jefferies Financial GroupDowngradeBuy ➝ Hold
(Data available from 7/6/2017 forward)

News Sentiment Rating

0.37 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/8/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/7/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/6/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/8/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/7/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/7/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/6/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/6/2022

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Recordati Industria Chimica e Farmaceutica logo
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
Read More

Today's Range

Now: $41.23
Low: $41.23
High: $41.23

50 Day Range

MA: $41.93
Low: $41.23
High: $42.03

52 Week Range

Now: $41.23
Low: $41.23
High: $41.23

Volume

N/A

Average Volume

479 shs

Market Capitalization

$8.51 billion

P/E Ratio

19.82

Dividend Yield

N/A

Beta

0.22

Frequently Asked Questions

What sell-side analysts currently cover shares of Recordati Industria Chimica e Farmaceutica?

The following equities research analysts have issued research reports on Recordati Industria Chimica e Farmaceutica in the last year: Barclays PLC, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., and Oddo Bhf.
View the latest analyst ratings for RCDTF.

What is the current price target for Recordati Industria Chimica e Farmaceutica?

0 Wall Street analysts have set twelve-month price targets for Recordati Industria Chimica e Farmaceutica in the last year. Their average twelve-month price target is $44.00, suggesting a possible upside of 6.7%.
View the latest price targets for RCDTF.

What is the current consensus analyst rating for Recordati Industria Chimica e Farmaceutica?

Recordati Industria Chimica e Farmaceutica currently has 1 sell rating and 3 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in RCDTF, but not buy more shares or sell existing shares.
View the latest ratings for RCDTF.

How do I contact Recordati Industria Chimica e Farmaceutica's investor relations team?

Recordati Industria Chimica e Farmaceutica's physical mailing address is Via Matteo Civitali 1, Milano L6, 20148. The company's listed phone number is 390-248-7871 and its investor relations email address is [email protected] The official website for Recordati Industria Chimica e Farmaceutica is www.recordati.com. Learn More about contacing Recordati Industria Chimica e Farmaceutica investor relations.